Genetic Analysis AS (XSAT:GEAN)
Sweden · Delayed Price · Currency is SEK · Price in NOK 0.7200
+0.0200 (2.86%)
At close: Dec 23, 2025
Genetic Analysis AS Market Cap
Genetic Analysis AS has a market cap or net worth of 45.39 million as of December 26, 2025. Its market cap has increased by 82.64% in one year.
Market Cap
45.39M
Enterprise Value
35.64M
Revenue
20.45M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.72
Market Cap Chart
Since October 1, 2021, Genetic Analysis AS's market cap has decreased from 235.48M to 45.39M, a decrease of -80.72%. That is a compound annual growth rate of -32.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 23, 2025 | 45.39M | 85.59% |
| Dec 30, 2024 | 24.46M | -31.37% |
| Dec 29, 2023 | 35.64M | -34.69% |
| Dec 30, 2022 | 54.57M | -66.71% |
| Dec 30, 2021 | 163.91M | -30.39% |
| Oct 1, 2021 | 235.48M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Investor AB | 993.75B |
| Atlas Copco AB | 776.34B |
| AB Volvo | 593.79B |
| EQT AB | 417.11B |
| ASSA ABLOY AB | 394.77B |
| Skandinaviska Enskilda Banken AB | 380.66B |
| Sandvik AB | 371.67B |
| Swedbank AB | 358.29B |